FORA Forian: Quarterly Sales Growth

FORA (forian.com) - company brandmark

Forian Inc. (FORA) aims for leadership in data analytics for the medical and cannabis sectors by expanding its Chronos platform. However, stringent privacy regulations and customer acquisition costs are weighing on profits. The implementation of AI algorithms for the pharmaceutical sector supports growth. The pace of quarterly revenue growth reflects demand dynamics, where -3.00 represents the latest level.

FORA (Forian Inc) Revenue Dynamics QoQ history from 07/04/2022 to 05/30/2026

Analytical breakdowns for Forian (FORA)

- stock price and consensus target price:
- company stock capitalization data:
Analysis of all company metrics:Forian (FORA)
Mass-produced product of forian.com

Forian Inc. specialization in healthcare data consolidation requires a steady stream of operating funds, as evidenced by the current value of -3.00. Analyzing the QoQ revenue growth rate allows for the exclusion of short-term liquidity fluctuations by measuring the real dynamics of inflows between quarters, serving as a reliable filter for assessing the fundamental stability of this small-cap company.